Biocardiainc Stock Probability of Future Stock Price Finishing Over 2.2

BCDA Stock  USD 0.38  0.01  2.70%   
BiocardiaInc's implied volatility is one of the determining factors in the pricing options written on BiocardiaInc. Implied volatility approximates the future value of BiocardiaInc based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in BiocardiaInc over a specific time period. For example, 2024-05-17 PUT at $1.0 is a PUT option contract on BiocardiaInc's common stock with a strick price of 1.0 expiring on 2024-05-17. The contract was not traded in recent days and, as of today, has 23 days remaining before the expiration. The option is currently trading at a bid price of $0.4, and an ask price of $0.95. The implied volatility as of the 24th of April is 410.29. View All BiocardiaInc options

Closest to current price BiocardiaInc long PUT Option Payoff at Expiration

BiocardiaInc's future price is the expected price of BiocardiaInc instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of BiocardiaInc performance during a given time horizon utilizing its historical volatility. Check out BiocardiaInc Backtesting, BiocardiaInc Valuation, BiocardiaInc Correlation, BiocardiaInc Hype Analysis, BiocardiaInc Volatility, BiocardiaInc History as well as BiocardiaInc Performance.
For information on how to trade BiocardiaInc Stock refer to our How to Trade BiocardiaInc Stock guide.
  
The current year's Price Earnings To Growth Ratio is expected to grow to 0.07, whereas Price To Sales Ratio is forecasted to decline to 28.02. Please specify BiocardiaInc's target price for which you would like BiocardiaInc odds to be computed.

BiocardiaInc Target Price Odds to finish over 2.2

The tendency of BiocardiaInc Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 2.20  or more in 90 days
 0.38 90 days 2.20 
close to zero percent
Based on a normal probability distribution, the odds of BiocardiaInc to move over $ 2.20  or more in 90 days from now is close to zero percent (This BiocardiaInc probability density function shows the probability of BiocardiaInc Stock to fall within a particular range of prices over 90 days) . Probability of BiocardiaInc price to stay between its current price of $ 0.38  and $ 2.20  at the end of the 90-day period is about 82.16 .
Given the investment horizon of 90 days BiocardiaInc has a beta of 0.83 suggesting as returns on the market go up, BiocardiaInc average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding BiocardiaInc will be expected to be much smaller as well. Additionally BiocardiaInc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
   BiocardiaInc Price Density   
       Price  

Predictive Modules for BiocardiaInc

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BiocardiaInc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of BiocardiaInc's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.020.385.77
Details
Intrinsic
Valuation
LowRealHigh
0.061.286.67
Details
Naive
Forecast
LowNextHigh
0.010.375.77
Details
1 Analysts
Consensus
LowTargetHigh
3.644.004.44
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as BiocardiaInc. Your research has to be compared to or analyzed against BiocardiaInc's peers to derive any actionable benefits. When done correctly, BiocardiaInc's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in BiocardiaInc.

BiocardiaInc Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. BiocardiaInc is not an exception. The market had few large corrections towards the BiocardiaInc's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold BiocardiaInc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of BiocardiaInc within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-0.15
β
Beta against NYSE Composite0.83
σ
Overall volatility
0.04
Ir
Information ratio -0.03

BiocardiaInc Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of BiocardiaInc for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for BiocardiaInc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
BiocardiaInc generated a negative expected return over the last 90 days
BiocardiaInc has high historical volatility and very poor performance
BiocardiaInc has some characteristics of a very speculative penny stock
BiocardiaInc has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 477 K. Net Loss for the year was (11.57 M) with loss before overhead, payroll, taxes, and interest of (7.48 M).
BiocardiaInc currently holds about 8.61 M in cash with (9.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.49, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
BiocardiaInc has a frail financial position based on the latest SEC disclosures
Roughly 34.0% of the company shares are held by company insiders
Latest headline from news.google.com: Will BioCardia, Inc. Report Negative Q2 Earnings What You Should Know - Yahoo Movies UK

BiocardiaInc Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of BiocardiaInc Stock often depends not only on the future outlook of the current and potential BiocardiaInc's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BiocardiaInc's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding21.2 M
Cash And Short Term Investments1.1 M

BiocardiaInc Technical Analysis

BiocardiaInc's future price can be derived by breaking down and analyzing its technical indicators over time. BiocardiaInc Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of BiocardiaInc. In general, you should focus on analyzing BiocardiaInc Stock price patterns and their correlations with different microeconomic environments and drivers.

BiocardiaInc Predictive Forecast Models

BiocardiaInc's time-series forecasting models is one of many BiocardiaInc's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary BiocardiaInc's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about BiocardiaInc

Checking the ongoing alerts about BiocardiaInc for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for BiocardiaInc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
BiocardiaInc generated a negative expected return over the last 90 days
BiocardiaInc has high historical volatility and very poor performance
BiocardiaInc has some characteristics of a very speculative penny stock
BiocardiaInc has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 477 K. Net Loss for the year was (11.57 M) with loss before overhead, payroll, taxes, and interest of (7.48 M).
BiocardiaInc currently holds about 8.61 M in cash with (9.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.49, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
BiocardiaInc has a frail financial position based on the latest SEC disclosures
Roughly 34.0% of the company shares are held by company insiders
Latest headline from news.google.com: Will BioCardia, Inc. Report Negative Q2 Earnings What You Should Know - Yahoo Movies UK
When determining whether BiocardiaInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BiocardiaInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biocardiainc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biocardiainc Stock:
Check out BiocardiaInc Backtesting, BiocardiaInc Valuation, BiocardiaInc Correlation, BiocardiaInc Hype Analysis, BiocardiaInc Volatility, BiocardiaInc History as well as BiocardiaInc Performance.
For information on how to trade BiocardiaInc Stock refer to our How to Trade BiocardiaInc Stock guide.
Note that the BiocardiaInc information on this page should be used as a complementary analysis to other BiocardiaInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for BiocardiaInc Stock analysis

When running BiocardiaInc's price analysis, check to measure BiocardiaInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BiocardiaInc is operating at the current time. Most of BiocardiaInc's value examination focuses on studying past and present price action to predict the probability of BiocardiaInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BiocardiaInc's price. Additionally, you may evaluate how the addition of BiocardiaInc to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Is BiocardiaInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BiocardiaInc. If investors know BiocardiaInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BiocardiaInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.55)
Revenue Per Share
0.023
Quarterly Revenue Growth
(0.88)
Return On Assets
(1.14)
Return On Equity
(7.04)
The market value of BiocardiaInc is measured differently than its book value, which is the value of BiocardiaInc that is recorded on the company's balance sheet. Investors also form their own opinion of BiocardiaInc's value that differs from its market value or its book value, called intrinsic value, which is BiocardiaInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BiocardiaInc's market value can be influenced by many factors that don't directly affect BiocardiaInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BiocardiaInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if BiocardiaInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BiocardiaInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.